Govt may take up only NBRA Bill from healthcare sector in current session of parliament

February 27, 2013 by
Filed under: Healthcare, Other Verticals in Healthcare 

The Biotechnology Regulatory Authority of India Bill (NBRA Bill) is the only Bill in the health and pharma sectors which has found a place in the tentative list for transaction of business during the ongoing budget session of Parliament which has started on February 21.

 

Though there are several important Bills belonging to the health and pharma sectors like ART Bill, HIV/AIDS Bill, Ethical Guidelines for Biomedical Research on Human Subjects Bill, Central Drug Authority (CDA) Bill, Medical Devices Bill, etc., which have been waiting for introduction in Parliament, only NBRA has been included for transaction of business during the ongoing budget session of Parliament.

 

In fact, the NBRA Bill has repeatedly been finding a place in the tentative list for transaction of business for the last several sessions of Parliament. On several occasions, the NBRA Bill, drafted by the Department of Biotechnology (DBT), was almost introduced but was held back at the eleventh hour due to some technical lacunae or due to some political issues which took precedence over several important Bills including the NBRA Bill.

 

But, sources now say that the introduction of this crucial Bill during the ongoing budget session is almost certain if Parliament is not preoccupied by some other political storm as was witnessed during the last several sessions of Parliament. Otherwise, all technical hindrances have been removed for the introduction of the Bill, sources said.

 

In the tentative list of 20 new bills listed to be introduced during this session, NBRA Bill is the only Bill in the health and pharma sectors. The Bill is being introduced to establish Biotechnology Regulatory Authority of India to regulate research, import, transport, use of organisms and product produced from modern biotechnology.

 

The Bill seeks to make NBRA as an independent, autonomous, statutory agency to safeguard the health and safety of the people of India and to protect the environment by identifying risks posed by, or as a result of, modern biotechnology, and managing those risks through regulating the safe development and deployment of biotechnology products and processes.

 

Source : February 25, 2013, 0800 IST РPharmabiz News

 

Comments

Tell me what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!





  • Value Added Connects

  • Categories

  • Subscribe With Us

    Enter your email address:

  • Recent Posts

  • Connect with Us

  • Follow Us on Twitter

  • Calendar

    February 2013
    M T W T F S S
    « Jan   Mar »
     123
    45678910
    11121314151617
    18192021222324
    25262728  
  • No. of Hits

    vBulletin counter